Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Unique immune cell fingerprint can help rapidly identify better treatment for autoimmune disease

Most autoimmune diseases are easy to diagnose but hard to treat. A paper published today in Science proposes using your unique immune cell fingerprint to rapidly identify which treatments will work for your autoimmune disease.

7 Apr 2022

Researchers design RNA molecules for delivering therapies directly to beta cells

Investigators at the University of Miami Miller School of Medicine have designed RNA molecules that home to human pancreatic beta cells, the cells that produce insulin and are destroyed in patients with type 1 and type 2 diabetes.

7 Apr 2022

Insufficient sleep could play a role in the development of type 2 diabetes

People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found.

6 Apr 2022

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Critical Path Institute's Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency has issued a positive qualification opinion for pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes (T1D) prevention trials.

5 Apr 2022

People who consume sugar for extended periods have increased risk of autoimmune disease

People who consume sugar and other carbohydrates in excess over a long period of time have an increased risk of developing an autoimmune disease.

23 Mar 2022

Using a new data-driven approach to understand more about people with Type 1 diabetes

An interdisciplinary team of researchers from the University of Missouri, Children's Mercy Kansas City and Texas Children's Hospital has used a new data-driven approach to learn more about persons with Type 1 diabetes, who account for about 5-10% of all diabetes diagnoses.

21 Mar 2022

Children with complex medical conditions often need out-of-network care, study finds

Children with complex medical conditions, especially those who require behavioral health treatment, often have to go outside of their insurance plans' provider networks for care, a new study has found.

21 Mar 2022

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Children who develop type 1 diabetes show epigenetic changes in the cells of their immune system already before the antibodies of the disease are detected in their blood.

16 Mar 2022

Exercise counters inflammation that leads to diabetes, depression after COVID-19

While no medically recognized treatment exists for Long COVID, exercise may break the vicious cycle of inflammation that can lead to developing diabetes and depression months after a person recovers from the virus.

11 Mar 2022

High prevalence of new-onset diabetes with ketoacidosis observed in children during COVID-19 pandemic

Research revealed the incidence of type 1 diabetes mellitus with severe diabetic ketoacidosis has increased among genetically susceptible children during the COVID-19 pandemic.

9 Mar 2022

$35 insulin cap is welcome, popular, and bipartisan. But Congress may not pass it anyway.

Democrats in the Senate are primed this month to make their first attempt at salvaging one of the most popular elements of President Joe Biden’s stalled Build Back Better plan — the proposal to cap insulin costs at $35 a month.

4 Mar 2022

Researchers take pioneering efforts to optimize the functionality of pancreatic cells produced from stem cells

Helsingin yliopisto (University of Helsinki) Insulin is a vital hormone produced by pancreatic beta cells. Type 1 diabetes is caused by the destruction of these cells, which results in patients having to replace the lost insulin with multiple daily injections.

4 Mar 2022

Study identifies new ways to enhance SC-beta cell survivability through genetic manipulation

Recent advances in the transplantation of stem cell-derived insulin-producing beta cells (SC-beta cells) to treat type 1 diabetes (T1D) has generated considerable interest and excitement.

3 Mar 2022

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications.

3 Mar 2022

Fact check: Biden sets high bar in 1st State of the Union speech

President Joe Biden argued forcefully for the power of democracy while calling out Russia's invasion of Ukraine in a March 1 State of the Union address that soon turned to the domestic concerns of the economy, inflation, and covid-19.

2 Mar 2022

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Researchers at Massachusetts General Hospital, in partnership with NYU Langone Health, have launched a multi-center clinical trial to investigate a new treatment for pediatric type 1 diabetes even in subjects with established disease.

1 Mar 2022

Study provides new understanding of the earliest molecular events in Type 1 Diabetes pathogenesis

For the first time, researchers have revealed that during the development of Type 1 Diabetes (T1D), when insulin-producing cells in the pancreas are under attack from T lymphocytes, the cells lining the pancreatic duct reprogram themselves in an attempt to suppress autoimmune T cell responses.

28 Feb 2022

Study reveals new way viruses trigger autoimmunity

Autoimmune diseases such as rheumatoid arthritis and Type 1 diabetes are thought to arise when people with a genetic susceptibility to autoimmunity encounter something in the environment that triggers their immune systems to attack their own bodies.

28 Feb 2022

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

A recent study has demonstrated that although the incidence of type 1 diabetes increases among children during the COVID-19 pandemic, previous infection by SARS-CoV-2 does not directly act as a causal factor.

15 Feb 2022

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

A central feature of type 1 diabetes is loss of the pancreatic beta cells that make insulin. Researchers led by Paolo Fiorina, MD, PhD, of Boston Children's Hospital and Francesca D'Addio, MD, of the University of Milan now identify a harmful cellular pathway that causes these cells to die.

3 Feb 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Unique immune cell fingerprint can help rapidly identify better treatment for autoimmune disease

Researchers design RNA molecules for delivering therapies directly to beta cells

Insufficient sleep could play a role in the development of type 2 diabetes

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

People who consume sugar for extended periods have increased risk of autoimmune disease

Using a new data-driven approach to understand more about people with Type 1 diabetes

Children with complex medical conditions often need out-of-network care, study finds

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Exercise counters inflammation that leads to diabetes, depression after COVID-19

High prevalence of new-onset diabetes with ketoacidosis observed in children during COVID-19 pandemic

$35 insulin cap is welcome, popular, and bipartisan. But Congress may not pass it anyway.

Researchers take pioneering efforts to optimize the functionality of pancreatic cells produced from stem cells

Study identifies new ways to enhance SC-beta cell survivability through genetic manipulation

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Fact check: Biden sets high bar in 1st State of the Union speech

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Study provides new understanding of the earliest molecular events in Type 1 Diabetes pathogenesis

Study reveals new way viruses trigger autoimmunity

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in